Side effects of and compliance with malaria prophylaxis in children

Journal of Travel Medicine

Volumn 9, Issue 6, 2002, Pages 289-292

  Albright, Theresa A ^a   Binns, Helen J ^a   Katz, Ben Z ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE;

ADOLESCENT; ANOREXIA; ANXIETY DISORDER; ARTICLE; CHILD; DEPRESSION; DIARRHEA; FEMALE; HALLUCINATION; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; MALE; NAUSEA; NIGHTMARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRESCRIPTION; PROPHYLAXIS; RASH; RETROSPECTIVE STUDY; SEIZURE; SLEEP DISORDER; TRAVEL; VIVID DREAM; VOMITING; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DREAM; DRUG EFFECT; INFANT; PRESCHOOL CHILD; STATISTICS; TREATMENT REFUSAL; UNITED STATES;

ADOLESCENT; ANOREXIA; ANTIMALARIALS; CHICAGO; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DIARRHEA; DREAMS; EXANTHEMA; FEMALE; HALLUCINATIONS; HUMANS; INFANT; MALARIA; MALE; MEFLOQUINE; NAUSEA; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TRAVEL; TREATMENT REFUSAL; VOMITING;

EID: 0036861554     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2002.30091     Document Type: Article

References (11)

1. Wyler DJ. Malaria chemoprophylaxis for the traveler. N Engl J Med 1993; 329:31-37.
2. Barrett J, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: Postal and telephone survey of travelers. BMJ 1996; 313:525-528.
3. Schlagenhauf P, Steffen R, Lobel H, et al. Mefloquine tolerability during chemoprophylaxis: Focus on adverse event assessments, stereochemistry and compliance. Trop Med Internation Health 1996; 4:485-494.
4. Petersen E, Ronne T, Ronn A, et al. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers. J Travel Med 2000; 7:79-84.
5. Hill DR. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 2000; 7:259-266.
6. Luxemburger C, Price R, Nosten F, et al. Mefloquine in infants and young children. Ann Trop Pediatr 1996; 16:281-286.
7. Ziai M, Amirhakimi GH, Reinhold JG, et al. Malaria prophylaxis and treatment in G-6-PD deficiency: An observation on the toxicity of primaquine and chloroquine. Clin Pediatr 1967; 6:242-243.
8. Gozal G, Fadat G, Hengy C. Long-term chloroquine-proguanil prophylaxis in a nonimmune pediatric population. J Pediatr 1991; 118:142-145.
9. Ortel B, Sivayathorn A, Honigsmann H. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy. Dermatologica 1989; 178:39-42.
10. Havaldar PV, Mogale KD. Mefioquine-induced psychosis. Pediatr Infect Dis J 2000; 19:166-167.
11. Selvaag E. Skin depigmentation due to antimalarial prophylaxis with chloroquine. Trans Roy Soc Trop Med Hyg 1996; 90:683.